ADD CONDITION

items per page

Refresh Digital Pf

Last content change checked dailysee data sync status

Active ingredients
  • Glycerin 10 mg/1 mL
  • Carboxymethylcellulose Sodium 5 mg/1 mL
  • Polysorbate 80 5 mg/1 mL
Drug class
Non-Standardized Chemical Allergen
Dosage form
Solution/ Drops
Route
Ophthalmic
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2020
Label revision date
November 28, 2022
Active ingredients
  • Glycerin 10 mg/1 mL
  • Carboxymethylcellulose Sodium 5 mg/1 mL
  • Polysorbate 80 5 mg/1 mL
Drug class
Non-Standardized Chemical Allergen
Dosage form
Solution/ Drops
Route
Ophthalmic
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2020
Label revision date
November 28, 2022
Manufacturer
Allergan, Inc.
Registration number
M018
NDC root
0023-6954

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Refresh® DIGITAL PF is a type of lubricant eye drop designed to provide temporary relief from burning, irritation, and discomfort caused by dry eyes or exposure to wind and sun. It contains HydroCell™, which helps to soothe your eyes and may also act as a protectant against further irritation.

These eye drops come in convenient vials, making them easy to use whenever you need fast-acting relief. Whether you're working on a computer for long hours or spending time outdoors, Refresh® DIGITAL PF can help keep your eyes comfortable and hydrated.

Uses

If you're experiencing burning, irritation, or discomfort in your eyes due to dryness or exposure to wind or sun, this product can provide temporary relief. It helps soothe your eyes and makes them feel more comfortable.

Additionally, it can act as a protectant, helping to shield your eyes from further irritation. This means that not only can it alleviate your current discomfort, but it can also help prevent additional issues caused by environmental factors.

Dosage and Administration

To use this medication, you should instill 1 or 2 drops directly into the affected eye or eyes whenever you feel it's necessary. After using the drops, be sure to discard the container to ensure safety and hygiene. It's important to follow this guideline to help manage your eye condition effectively.

What to Avoid

It's important to be aware of certain situations where you should not use this medication. Specifically, you should avoid using it if you experience eye pain, changes in vision, ongoing redness or irritation of the eye, or if your condition worsens or does not improve after 72 hours.

Currently, there are no specific contraindications, controlled substance classifications, or noted risks of abuse, misuse, or dependence associated with this medication. However, always prioritize your health and consult a healthcare professional if you have any concerns or questions.

Side Effects

If you experience any eye pain, changes in your vision, or ongoing redness or irritation of the eye, it’s important to stop using the medication and consult your doctor. Additionally, if your condition worsens or does not improve after 72 hours, seek medical advice promptly. Your health and safety are paramount, so don’t hesitate to reach out for help if you notice any concerning symptoms.

Warnings and Precautions

This product is for external use only, so please avoid applying it to any internal areas. To keep the solution clean, do not touch the tip of the container to any surface, and do not reuse it once opened—make sure to discard it properly. Additionally, avoid letting the unit-dose tip come into contact with your eye.

If you notice any changes in the color of the solution, do not use it. You should stop using the product and contact your doctor if you experience eye pain, changes in your vision, ongoing redness or irritation of the eye, or if your condition worsens or does not improve after 72 hours. If the solution is swallowed, seek medical help or contact a Poison Control Center immediately.

Overdose

If you or someone else has swallowed a medication and you suspect an overdose, it’s important to act quickly. You should seek medical help immediately or contact a Poison Control Center. They can provide guidance on what to do next.

Signs of an overdose can vary, but they may include unusual symptoms that are not typical for the medication. If you notice any concerning changes in behavior or health, don’t hesitate to reach out for help. Remember, it’s always better to be safe and get professional advice in these situations.

Pregnancy Use

Currently, there is no specific information available about the use of REFRESH DIGITAL PF during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions for pregnant individuals have not been addressed in the provided information.

If you are pregnant or planning to become pregnant, it is always best to consult with your healthcare provider before using any medication, including REFRESH DIGITAL PF, to ensure it is safe for you and your baby.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. This means that, according to the information available, it is considered safe for you to use without concerns about potential effects on your milk production or the nursing infant.

Additionally, there are no indications that this product is excreted in breast milk, which further supports its use during lactation. Always consult with your healthcare provider if you have any questions or concerns about medications while breastfeeding.

Pediatric Use

It's important to keep this medication out of reach of children to prevent accidental ingestion. If your child swallows any of it, seek medical help immediately or contact a Poison Control Center for guidance. Taking these precautions can help ensure your child's safety.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or safety considerations related to renal impairment (kidney issues). This means that there are no tailored recommendations for how your treatment may need to change based on your kidney function.

Always consult your healthcare provider for personalized advice and to ensure that your treatment is safe and effective, especially if you have any concerns about your kidney health. They can provide the necessary guidance based on your individual situation.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver condition and the use of this medication. They can help ensure that you receive the safest and most effective treatment.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking. In this case, there are no specific drug interactions or laboratory test interactions noted, which means that the medication is generally considered safe to use with other drugs and tests. However, every individual is different, and your healthcare provider can help ensure that your treatment plan is safe and effective for you.

Always discuss any changes in your medications or upcoming lab tests with your healthcare provider to avoid any potential issues and to ensure the best care for your health.

Storage and Handling

To ensure the safety and effectiveness of your product, always use it only if the single-use container is intact and has not been damaged. Be sure to check the expiration date marked on the container and use the product before that date. For optimal storage, keep the product in a cool, dry place at a temperature between 59°F and 77°F (15°C and 25°C).

It's also important to retain the carton for future reference, as it contains valuable information that may be useful later. Following these guidelines will help you handle the product safely and effectively.

Additional Information

No further information is available.

FAQ

What is Refresh® DIGITAL PF?

Refresh® DIGITAL PF is a lubricant eye drop designed to provide temporary relief from eye dryness, burning, irritation, and discomfort.

How does Refresh® DIGITAL PF work?

It works by soothing the eyes and may act as a protectant against further irritation caused by dryness or exposure to wind or sun.

How should I use Refresh® DIGITAL PF?

Instill 1 or 2 drops in the affected eye(s) as needed and discard the container after use.

Are there any contraindications for using Refresh® DIGITAL PF?

No specific contraindications are listed for this product.

What should I do if I experience eye pain or changes in vision?

Stop using Refresh® DIGITAL PF and consult a doctor if you experience eye pain, changes in vision, or if the condition worsens or persists for more than 72 hours.

Is Refresh® DIGITAL PF safe for children?

Keep Refresh® DIGITAL PF out of reach of children, and if swallowed, seek medical help or contact a Poison Control Center immediately.

Can I use Refresh® DIGITAL PF during pregnancy or while nursing?

There are no specific warnings or recommendations regarding the use of Refresh® DIGITAL PF during pregnancy or lactation.

What should I do if the solution changes color?

If the solution changes color, do not use it.

How should I store Refresh® DIGITAL PF?

Store it at 59°-77°F (15°-25°C) and use it before the expiration date marked on the container.

Packaging Info

Below are the non-prescription pack sizes of Refresh Digital Pf (carboxymethylcellulose sodium, glycerin and polysorbate 80). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Refresh Digital Pf.
Details

Drug Information (PDF)

This file contains official product information for Refresh Digital Pf, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Refresh® DIGITAL PF is a sterile lubricant eye drop formulation designed to provide fast-acting relief for eye dryness. Each vial contains 0.01 fluid ounces (0.4 mL) of the solution, and the product is packaged in a total of 30 vials. The formulation incorporates HydroCell™ technology, which aids in soothing the eyes. The product is identified by the National Drug Code (NDC) 0023-6954-30.

Uses and Indications

This drug is indicated for the temporary relief of burning, irritation, and discomfort due to dryness of the eye or exposure to wind or sun. It may also be used as a protectant against further irritation.

Limitations of Use: This product is intended for symptomatic relief and does not address underlying causes of eye dryness.

Dosage and Administration

Healthcare professionals are advised to instill 1 or 2 drops of the medication into the affected eye(s) as needed. After use, the container should be discarded to ensure proper hygiene and prevent contamination.

Contraindications

Use is contraindicated in patients experiencing eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours. These conditions may indicate a more serious underlying issue that requires medical evaluation.

Warnings and Precautions

For external use only. To prevent contamination, it is imperative that the tip of the container not be touched to any surface. The container is designed for single use; once opened, it should be discarded and not reused.

Care should be taken to avoid contact between the unit-dose tip and the eye. If the solution exhibits any change in color, it must not be used.

In the event of experiencing eye pain, changes in vision, persistent redness or irritation of the eye, or if the condition worsens or does not improve within 72 hours, the user should discontinue use and consult a healthcare professional.

In cases of accidental ingestion, immediate medical assistance should be sought, or the user should contact a Poison Control Center without delay.

Side Effects

Patients should discontinue use and consult a healthcare professional if they experience any of the following serious adverse reactions: eye pain, changes in vision, persistent redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours. These symptoms may indicate a more serious underlying condition that requires medical evaluation.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Refresh Digital Pf (carboxymethylcellulose sodium, glycerin and polysorbate 80). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Refresh Digital Pf.
Details

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information available regarding the use of REFRESH DIGITAL PF during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this product to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled accordingly.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available concerning the potential for excretion of this product in breast milk or its effects on breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

In all cases of suspected overdosage, the involvement of poison control experts is recommended to guide the management and ensure the best possible care for the patient.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: eye pain, changes in vision, continued redness or irritation of the eye, and worsening or persistent conditions beyond 72 hours.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Additionally, patients should be informed to discontinue use and consult a doctor if they experience any of the following symptoms: eye pain, changes in vision, persistent redness or irritation of the eye, or if their condition worsens or does not improve after 72 hours. It is important for healthcare providers to ensure that patients understand these critical safety measures to promote their well-being while using the medication.

Storage and Handling

The product is supplied in single-use containers, which should only be utilized if the container remains intact. It is essential to observe the expiration date indicated on the container and ensure that the product is used before this date.

For optimal storage conditions, the product must be kept at a temperature range of 59° to 77°F (15° to 25°C). Additionally, it is important to retain the carton for future reference regarding the product's details and instructions.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Refresh Digital Pf, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Refresh Digital Pf, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.